ArticleESC heart failure2020

Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.

Christoph Wanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.